Prenatal Diagnostics Market

Prenatal Diagnostics Market was valued at USD xx Million in 2018, and is estimated to reach at xx Million by 2025, registering a CAGR of xx% over the forecast period.

Scope of Prenatal Diagnostics Market-

Prenatal diagnostics is a method for testing the baby before birth to decide certain innate issues such as; down's disorder, hereditary infections, chromosome variations from the norm, neural cylinder imperfections, and different conditions. If there would arise an occurrence of high hazard identified with the introduction of a kid, it can help by directing various strategies of hereditary testing regular testing. Prenatal screening centers around discovering issues among a huge populace with moderate and noninvasive techniques. Pre-birth determination centers around seeking after extra nitty gritty data once a specific issue has been found, and can some of the time be progressively obtrusive. The most widely recognized screening methods are normal ultrasounds, blood tests, and circulatory strain estimation. Normal determination systems incorporate amniocentesis and chorionic villus testing.

Prenatal Diagnostics Market report is segmented on the basis of type, end-user and regional & country level. Based upon type, prenatal diagnostics market is segmented into type first-trimester screening tests, second-trimester screening tests, third-trimester screening tests and diagnostic tests. Based upon end-user, prenatal diagnostics market is segmented into hospitals, gynecology clinics, pathology labs and others.

The regions covered in this Prenatal Diagnostics market report are North America, Europe, Asia-Pacific and Rest of the World. On the basis of country level, market of Prenatal Diagnostics market is sub divided into U.S., Mexico, Canada, UK, France, Germany, Italy, China, Japan, India, South East Asia, GCC, Africa, etc.

Key Players of Prenatal Diagnostics Market-

Key market players, of Prenatal Diagnostics market are like 

• Agilent Technologies, Inc.
• BGI Genomics
• CooperSurgical, Inc.
• Eurofins Scientific
• Hoffmann-La Roche Ltd.
• Illumina, Inc.
• Invitae Corporation
• Laboratory Corporation of America Holdings (LabCorp)
• LifeCodexx AG
• Myriad Genetics, Inc.
• Natera, Inc.
• PerkinElmer, Inc.
• Quest Diagnostics Incorporated
• Roche Holding AG
• Thermo Fisher Scientific, Inc.
• Others

Market Segmentation of Prenatal Diagnostics-

By Test Type

• Non-Invasive Prenatal Testing (NIPT)
• Maternal Serum Screening (MSS)
• Ultrasound
• Chorionic Villus Sampling (CVS)
• Amniocentesis
• Others

By Mode of Screening

• First-Trimester Screening
• Second-Trimester Screening
• Sequential Screening
• Others

By Technology

• Next-Generation Sequencing (NGS)
• Polymerase Chain Reaction (PCR)
• Biochemical Assays
• Ultrasound
• Others

By End-User

• Hospitals
• Diagnostic Laboratories
• Clinics
• Others

By Regional & Country Analysis:

• North America

• U.S.
• Mexico
• Canada

• Europe

• UK
• France
• Germany
• Italy

• The Asia Pacific

• China
• Japan
• India
• Southeast Asia

• South America

• Brazil,
• Argentina
• Columbia

• The Middle East and Africa

• GCC
• Africa
• Rest of the Middle East and Africa

Rising Maternal Average Age and Increasing Number of Stillbirths are the Major Factors Driving the Market Growth.

The major factors driving the growth of global prenatal diagnostics market are increasing number of stillbirths, increasing focus on genetic testing and  to reduce the financial burden of expensive neonatal intensive care. In addition, increasing technological advancements in safer non invasive prenatal testing, growing awareness about prenatal testing in emerging economies and increasing the disposable income of the population in emerging economies are also supplementing the market growth. However, strict regulatory framework and traditional ethical outlook towards prenatal testing can limit the growth of the prenatal diagnostics. Moreover, non-invasive prenatal tests and alternative screening and testing methods can also create hurdles for the market growth.

North America is Expected to Dominate the Global Prenatal Diagnostics Market.

The global utility terrain vehicle (UTV) market is segmented into North America, Europe, Asia-Pacific, Europe, Latin America and the Middle East and Africa. North America is expected to dominate the  global prenatal diagnostics market owing to the high adoption rate and increasing awareness about the benefits of prenatal diagnostics. Asia Pacific market for prenatal diagnostics is expeceted to show a fastest growth with highest CAGR within the forecast period. The growth in this region is attributed to increasing disposable income and improving healthcare infrastructure in this region.

Report Analysis	Details
Historical data	2016 - 2021
Forecast Period	2022 - 2029
Market Size in 2022:	USD XX Billion
Base year considered	2021
Forecast Period CAGR %:	XX%
Market Size Expected in 2029:	USD XX Billion
Tables, Charts & Figures:	175
Pages	300
Companies	Agilent Technologies, Inc., BGI Genomic, CooperSurgical, Inc., Eurofins Scientific, Hoffmann-La Roche Ltd., Illumina, Inc., Invitae Corporation, Laboratory Corporation of America Holdings , LabCorp), LifeCodexx AG, Myriad Genetics, Inc., Natera, Inc., PerkinElmer, Inc., Quest Diagnostics Incorporated, Roche Holding AG, Thermo Fisher Scientific, Inc., Others.
Segments Covered	By Type, By End-User
Regional Analysis	North America, U.S., Mexico, Canada, Europe, UK, France, Germany, Italy, Asia Pacific, China, Japan, India, Southeast Asia, South America, Brazil, Argentina, Columbia, The Middle East and Africa, GCC, Africa, Rest of the Middle East and Africa